These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Clinical Characteristics of Connective Tissue Disease-Associated Interstitial Lung Disease in 1,044 Chinese Patients. Hu Y; Wang LS; Wei YR; Du SS; Du YK; He X; Li N; Zhou Y; Li QH; Su YL; Zhang F; Shen L; Weng D; Brown KK; Li HP Chest; 2016 Jan; 149(1):201-8. PubMed ID: 26447566 [TBL] [Abstract][Full Text] [Related]
26. New treatment paradigms for connective tissue disease-associated interstitial lung disease. Kouranos V; Miranda G; Corte TJ; Renzoni EA Curr Opin Pulm Med; 2018 Sep; 24(5):453-460. PubMed ID: 30020142 [TBL] [Abstract][Full Text] [Related]
27. Vitamin D deficiency in connective tissue disease-associated interstitial lung disease. Deng M; Tang L; Huang D; Wang Z; Chen J Clin Exp Rheumatol; 2018; 36(6):1049-1055. PubMed ID: 29846166 [TBL] [Abstract][Full Text] [Related]
28. Roles of TRIM21/Ro52 in connective tissue disease-associated interstitial lung diseases. Gong X; He S; Cai P Front Immunol; 2024; 15():1435525. PubMed ID: 39165359 [TBL] [Abstract][Full Text] [Related]
30. Determining respiratory impairment in connective tissue disease-associated interstitial lung disease. Assayag D; Ryerson CJ Rheum Dis Clin North Am; 2015 May; 41(2):213-23. PubMed ID: 25836638 [TBL] [Abstract][Full Text] [Related]
31. Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF). Jee AS; Adelstein S; Bleasel J; Keir GJ; Nguyen M; Sahhar J; Youssef P; Corte TJ J Clin Med; 2017 May; 6(5):. PubMed ID: 28471413 [TBL] [Abstract][Full Text] [Related]
32. Current and emerging treatment options for interstitial lung disease in patients with rheumatic disease. Lee JS; Fischer A Expert Rev Clin Immunol; 2016; 12(5):509-20. PubMed ID: 26752397 [TBL] [Abstract][Full Text] [Related]
33. Clinical Features of Idiopathic Interstitial Pneumonia with Systemic Sclerosis-Related Autoantibody in Comparison with Interstitial Pneumonia with Systemic Sclerosis. Yamakawa H; Hagiwara E; Kitamura H; Yamanaka Y; Ikeda S; Sekine A; Baba T; Iso S; Okudela K; Iwasawa T; Takemura T; Kuwano K; Ogura T PLoS One; 2016; 11(8):e0161908. PubMed ID: 27564852 [TBL] [Abstract][Full Text] [Related]
36. Targeting CD20 in the treatment of interstitial lung diseases related to connective tissue diseases: A systematic review. Bellan M; Patrucco F; Barone-Adesi F; Gavelli F; Castello LM; Nerviani A; Andreoli L; Cavagna L; Pirisi M; Sainaghi PP Autoimmun Rev; 2020 Feb; 19(2):102453. PubMed ID: 31838163 [TBL] [Abstract][Full Text] [Related]
37. Lung Cancer development and mortality in interstitial lung disease with and without connective tissue diseases: a five-year Nationwide population-based study. Choi WI; Lee DY; Choi HG; Lee CW Respir Res; 2019 Jun; 20(1):117. PubMed ID: 31182103 [TBL] [Abstract][Full Text] [Related]